9 research outputs found

    Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.

    No full text

    Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

    No full text
    corecore